Regeneron will use trove of 23andMe genetic data to develop medical advances.
#stockmarket #breaking
Biotech company Regeneron to buy bankrupt 23andMe for $256M – Ars Technica $GOOG $NVDA $MSFT
Related Posts
Dollar stands tall in 2024, propped up by cautious Fed, Trump trade – Yahoo Finance $DJT #Trump
The dollar slipped on the last trading day of the year on Tuesday but was poised to clock strong gains…
Forbes 2025 list of wealthiest Americans is out – From tech titans to retail moguls, who tops the list? – Mint
Forbes’ 2025 list of the 400 wealthiest Americans shows major shifts in wealth, highlighting trends across technology, finance, and retail.…
In-N-Out to close longtime headquarters as company prepares to open Nashville office – USA TODAY
In-N-Out announced that it will close its Irvine office by 2029 on Monday as it readies to open dual headquarters,…